[1]
I. Savić and D. Oprić, “PD-1/PD-L1: A NOVEL TARGET FOR IMMUNOTHERAPY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER”, MedPodml, vol. 69, no. 2, Jun. 2018, doi: 10.5937/mp69-15842.